Injectable supramolecular hydrogel for topical delivery of DPPA-1 peptides and DOX. On the one hand, DOX can directly kill tumor cells or induce immunogenic cell death. On the other hand, DPPA-1 peptides can locally block the PD-1/PD-L1 pathway. This evidence concerns the gene CD274 and neoplasm.